LPAR1 and peripheral nerve injury: To test whether LPA receptors could participate in paclitaxel-induced neuropathic pain, we used mice deficient in LPA1 or LPA3 receptors, both of which are required for the development of peripheral nerve injury-induced neuropathic pain [7, 13].